Literature DB >> 27346697

Association between KIR genotypes and HLA-B alleles on viral load in Southern Brazilian individuals infected by HIV-1 subtypes B and C.

Juliana Fernandes-Cardoso1, Theodoro Armando Süffert2, Maria da Gloria Correa2, Luiz Fernando Job Jobim3, Mariana Jobim3, Patricia Hartstein Salim3, Monica Barcelos Arruda4, Lidia Theodoro Boullosa4, Amilcar Tanuri4, Luis Cristóvão Porto1, Orlando C Ferreira5.   

Abstract

There is a great variety of HIV-1 subtypes circulating in Brazil, including subtype C, whose prevalence is on the rise, particularly in the southern region. Many host and viral genetic factors may be involved in this trend. We evaluated the influence of human leukocyte antigen (HLA) class I alleles and killer-cell immunoglobulin-like receptor (KIR) genotypes on viral set point and T-CD4(+) parameters in 84 treatment-naïve HIV-1-positive individuals. Frequency data in the infected group were compared to data of 548 healthy control subjects. Individuals with the KIR AA genotype had a higher viral load (VL) than individuals with the KIR Bx genotype. The HIV-1 group was subdivided into three subgroups according to HLA-B allele presence: those with protection to disease alleles (HLA-B(+)), accelerated disease progression alleles (HLA-B(-)), or neither (HLA-B(o)) were grouped. We observed a significant effect of the HLA-B allele presence on VL. The HLA-B(+) group had significantly lower VL than the HLA-B(-) group and trended toward a lower VL than the HLA-B(o) group. There were significant differences between groups expressing extreme VL values: KIR-AA+HLA-B(-) vs. KIR Bx+HLA-B(+) and KIR-AA+HLA-B(o)vs. KIR Bx+HLA-B(+). The relationship of KIR/HLA host genetics with slow HIV disease progression in southern Brazil may be useful for vaccine developers, epidemiologists, and clinicians.
Copyright © 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disease progression; HIV; HLA; KIR genotype; Viral load

Mesh:

Substances:

Year:  2016        PMID: 27346697     DOI: 10.1016/j.humimm.2016.06.013

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  1 in total

1.  Clinical and genetic markers associated with tuberculosis, HIV-1 infection, and TB/HIV-immune reconstitution inflammatory syndrome outcomes.

Authors:  Nathalia Beatriz Ramos de Sá; Marcelo Ribeiro-Alves; Tatiana Pereira da Silva; Jose Henrique Pilotto; Valeria Cavalcanti Rolla; Carmem B W Giacoia-Gripp; Daniel Scott-Algara; Mariza Gonçalves Morgado; Sylvia Lopes Maia Teixeira
Journal:  BMC Infect Dis       Date:  2020-01-20       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.